Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Disynthesis Chemical Technology is a contract research and manufacturing organization (CRMO) based in Hangzhou, China, specializing in medicinal chemistry and custom synthesis. The company provides a wide range of services to the global pharmaceutical and biotech industries, including the design and synthesis of chemical building blocks, intermediates, and reference standards. Their expertise spans lead optimization, process research and development, and the production of high-quality impurities for drug analysis. With a focus on small molecule drug discovery, Disynthesis supports clients through FTE-based collaborations and project-based custom synthesis. The company maintains advanced laboratory facilities to ensure rigorous quality control and timely delivery of complex chemical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Disynthesis Chemical Technology.